India's biggest drugmaker Sun Pharmaceutical Industries on Friday reported an increase of 258% in net profit after tax to ₹1,417 crore for the quarter ended December. Net sales increased by 2.3% to ₹7,046.57 crore. The company's share price spiked over 5% following the announcement of the quarterly results, before ending 1.45% higher.
